Rapidly progressive glomerulonephritis with D-penicillamine

Citation
Y. Nanke et al., Rapidly progressive glomerulonephritis with D-penicillamine, AM J MED SC, 320(6), 2000, pp. 398-402
Citations number
30
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
ISSN journal
00029629 → ACNP
Volume
320
Issue
6
Year of publication
2000
Pages
398 - 402
Database
ISI
SICI code
0002-9629(200012)320:6<398:RPGWD>2.0.ZU;2-X
Abstract
We present 3 cases of anti-myeloperoxidase, anti-neutrophil cytoplasmic ant ibody (MPO-ANCA)-positive rapidly progressive glomerulonephritis developed during the treatment with D-penicillamine (D-PC) for rheumatoid arthritis. Rheumatoid arthritis was diagnosed in these patients, and D-PC was administ ered to them at doses of 100, 200, and 300 mg per day for 321 42, and 39 mo nths, respectively. They developed proteinuria, hematuria, renal insufficie ncy, and anemia, and D-PC was stopped. On admission, MPO-ANCA was strongly positive in their sera. Renal biopsy showed glomerulonephritis with cellula r crescents. Immunofluorescence examination revealed deposits of granular I gG, IgM, IgA, C1q, and C3 in the mesangium. The 3 patients were treated wit h steroid pulse therapy along With administration of anticoagulants, and cy clophosphamide was also used in 2 patients. Their renal function improved g radually and MPO-ANCA disappeared after immunosuppressive treatment.